GC Cell Corporation (KOSDAQ:144510)
16,300
-200 (-1.21%)
Jun 10, 2026, 3:30 PM KST
GC Cell Revenue
GC Cell had revenue of 37.37B KRW in the quarter ending March 31, 2026, a decrease of -5.50%. This brings the company's revenue in the last twelve months to 163.35B, down -5.53% year-over-year. In the year 2025, GC Cell had annual revenue of 165.52B, down -5.12%.
Revenue (ttm)
163.35B
Revenue Growth
-5.53%
P/S Ratio
1.52
Revenue / Employee
234.02M
Employees
698
Market Cap
247.95B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 165.52B | -8.93B | -5.12% |
| Dec 31, 2024 | 174.45B | -13.09B | -6.98% |
| Dec 31, 2023 | 187.54B | -48.58B | -20.57% |
| Dec 31, 2022 | 236.12B | 67.81B | 40.29% |
| Dec 31, 2021 | 168.31B | 82.75B | 96.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EASY BIO,Inc. | 490.70B |
| Bioneer | 338.01B |
| BINEX | 164.00B |
| JETEMA, | 77.07B |
| HLB Therapeutics | 67.56B |
| SillaJen | 10.92B |
| Anterogen.Co.,Ltd. | 8.06B |
| Genomictree | 3.83B |